Do we differ in terms of indications and demographics in cardiac resynchronisation recipients in Poland? Insights from the European CRT Survey II Registry.


Journal

Kardiologia polska
ISSN: 1897-4279
Titre abrégé: Kardiol Pol
Pays: Poland
ID NLM: 0376352

Informations de publication

Date de publication:
Historique:
received: 15 08 2018
accepted: 07 11 2018
revised: 05 11 2018
pubmed: 9 11 2018
medline: 28 8 2019
entrez: 9 11 2018
Statut: ppublish

Résumé

Multiple randomised clinical trials have proven that cardiac resynchronisation therapy (CRT) reduces morbidity and mortality in appropriately selected patients with congestive heart failure and is recommended for such patients as per the European Society of Cardiology guidelines. In this paper we compare the indications and demographics in cardiac resynchronisation recipients in Poland and other European countries. In 2015 and 2016, physicians from 42 European countries participated in the second edition of the European Cardiac Resynchronisation Therapy Survey. For 14 months, 288 implanting centres gathered data regarding demography, indications, implanting methods, and guidance compatibility from 11,088 patients receiving CRT. The survey revealed that a vast group of patients were eligible for CRT implantation (although some of them with rela-tively weak guidance recommendations) and showed essential variety in clinical practice when national data were benchmarked. The population of CRT recipients in Poland and other European countries did not differ in terms of demographic and clinical characteristics. In most cases, indications for CRT were in accordance with the guidelines; however some devices were implanted in patients beyond the guideline recommendations. For these procedures, the decision regarding CRT im-plantation relies mainly on the physicians' experience.

Sections du résumé

BACKGROUND BACKGROUND
Multiple randomised clinical trials have proven that cardiac resynchronisation therapy (CRT) reduces morbidity and mortality in appropriately selected patients with congestive heart failure and is recommended for such patients as per the European Society of Cardiology guidelines.
AIM OBJECTIVE
In this paper we compare the indications and demographics in cardiac resynchronisation recipients in Poland and other European countries.
METHODS METHODS
In 2015 and 2016, physicians from 42 European countries participated in the second edition of the European Cardiac Resynchronisation Therapy Survey. For 14 months, 288 implanting centres gathered data regarding demography, indications, implanting methods, and guidance compatibility from 11,088 patients receiving CRT.
RESULTS RESULTS
The survey revealed that a vast group of patients were eligible for CRT implantation (although some of them with rela-tively weak guidance recommendations) and showed essential variety in clinical practice when national data were benchmarked.
CONCLUSIONS CONCLUSIONS
The population of CRT recipients in Poland and other European countries did not differ in terms of demographic and clinical characteristics. In most cases, indications for CRT were in accordance with the guidelines; however some devices were implanted in patients beyond the guideline recommendations. For these procedures, the decision regarding CRT im-plantation relies mainly on the physicians' experience.

Identifiants

pubmed: 30406939
pii: VM/OJS/KP/12556
doi: 10.5603/KP.a2018.0215
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

40-46

Auteurs

Damian Łasocha (D)

Department of Arrhythmia, Institute of Cardiology, Alpejska 42, 04-628 Warsaw, Poland. lasocha.damian@gmail.com.

Maciej Sterliński (M)

Department of Arrhythmia, Institute of Cardiology, Alpejska 42, 04-628 Warsaw, Poland.

Mateusz Tajstra (M)

3rd Chair and Clinical Department of Cardiology, Silesian Centre for Heart Diseases, Zabrze, Poland.

Krystian Josiak (K)

Departament of Heart Diseases, Medical University of Wroclaw, ul. Weigla 5, 53-114 Wroclaw, Poland.

Dariusz Zając (D)

2nd Coronary Artery Disease Department, Institute of Cardiology, Warsaw, Poland.

Sławomir Tłuczek (S)

Faculty of Medicine, University of Rzeszów, Al. Kopisto 2a, 35- 959 Rzeszów, Poland.

Adam Sokal (A)

Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Silesian Center for Heart Diseases, Zabrze; School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice.

Łukasz J Januszkiewicz (ŁJ)

1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Bogdan Galar (B)

Dept. of Cardiology, Hospital of the Ministry of Internal Affaires, Białostok, Poland.

Rafał Sznajder (R)

Department of Electrocardiology and Heart Failure, Leszek Giec Upper-Silesian Medical Centre, Katowice, Poland.

Jarosław Kaźmierczak (J)

Department of Cardiology, Pomeranian Medical University, ul. Powstańców Wlkp. 72, 70-111 Szczecin, Poland.

Łukasz Szumowski (Ł)

Department of Arrhythmia, Institute of Cardiology, Alpejska 42, 04-628 Warsaw, Poland.

Camilla Normand (C)

Cardiology Division, Stavanger University Hospital, Stavanger, Norway.

Cecilia Linde (C)

Heart and Vessels Theme, Karolinska University Hospital, Stockholm, and Karolinska Institutet, Stockholm, Sweden.

Kenneth Dickstein (K)

Cardiology Division, Stavanger University Hospital, Stavanger, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH